Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ukoniq
Pharma
FDA rescinds nod for TG Therapeutics' lymphoma drug Ukoniq
The FDA has rescinded its approval of TG Therapeutics' lymphoma drug Ukoniq because of concerns that its use might increase the risk of death.
Kevin Dunleavy
Jun 1, 2022 11:14am
FDA halts single-arm nods for PI3K blood cancer meds
Apr 20, 2022 9:57am
Novartis, BMS, Innovent, Lilly, Akebia await FDA decisions
Mar 2, 2022 10:10am
FDA probes TG Therapeutics' Ukoniq for potential death risks
Feb 7, 2022 9:53am
TG Therapeutics wins FDA nod for potentially safer Zydelig rival
Feb 8, 2021 11:31am
